Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta variant B.1.351 of SARS-CoV-2 which emerged in South Africa in December 2020 and reduces the effectiveness of some vaccines.
One unit allows the stimulation of 2,5 x 108 cells.
| Gene: | S | |
| Delivery: | overnight | |
| Counter Ion: | TFA | |
| Protein: | Spike glycoprotein | |
| UniProt Id: | P0DTC2 | |
| Species: | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Covid-19, Infection, Respiratory infection | |
| Amount/Aliquote : | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€253.50*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Product number:
LB01945